Publication:
Polyarteritis Nodosa in Patients With Familial Mediterranean Fever (FMF): A Concomitant Disease or a Feature of FMF

dc.authorscopusid7103280649
dc.authorscopusid7005411729
dc.authorscopusid7005272824
dc.authorscopusid59883225100
dc.authorscopusid7005391650
dc.authorscopusid7004688947
dc.authorscopusid7005732599
dc.contributor.authorOzen, S.
dc.contributor.authorBen-Chétrit, E.
dc.contributor.authorBakkaloĝlu, A.
dc.contributor.authorGur, H.
dc.contributor.authorTinaztepe, K.
dc.contributor.authorÇalgünerí, M.
dc.contributor.authorTurgan, C.
dc.date.accessioned2020-06-21T15:49:24Z
dc.date.available2020-06-21T15:49:24Z
dc.date.issued2001
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Ozen] Seza, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey; [Ben-Chétrit] Eldad, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel; [Bakkaloĝlu] Ayşin S., Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey; [Gur] Hanan, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel; [Tinaztepe] Keriman, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey; [Çalgünerí] Meral, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey; [Turgan] Çetin, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey; [Türkmen] Aydin, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey; [Akpolat] İlkser, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey, Faculty of Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Danaci] Murat, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey, Faculty of Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Bešbaš] Nesrin, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey; [Akpolat] Tekin, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey, Department of Medicine, Hadassah University Medical Centre, Jerusalem, Israel, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Medicine, Chaim Sheba Medical Center Israel, Tel Hashomer tel Aviv, Israel, Department of Internal Medicine, Hacettepe Üniversitesi, Ankara, Turkey, Department of Internal Medicine, Istanbul Üniversitesi, Istanbul, Turkey, Department of Medicine, Faculty of Medicine, Samsun, Edirne, Turkeyen_US
dc.description.abstractBackground: Familial Mediterranean fever (FMF) is caused by mutations in the gene encoding pyrin and is characterized by self-limited, recurrent attacks of fever and serositis. Vasculitis has been increasingly reported in FMF. A study evaluating the prognosis in FMF and polyarteritis nodosa (PAN) patients has not been reported previously. Objectives: To determine the special characteristics and the prognosis of PAN in FMF patients. Methods: A questionnaire was used for the present survey. The setting was 7 referral centers from Turkey and Israel. Seventeen patients who were diagnosed with FMF and who developed PAN were included. PAN was diagnosed in those who met the Chapel Hill consensus criteria for microscopic polyarteritis or classic PAN. The clinical features of these 17 patients and the outcomes of their vasculitis were analyzed. Results: The age at diagnosis of PAN in these FMF patients ranged from 3.5 to 37 years. All patients had constitutional symptoms, elevated acute phase reactants, and myalgia at the time PAN was diagnosed. The diagnosis of PAN was confirmed by renal angiography in 8 patients, by renal biopsy in 6 patients, and by muscle and/or nodule biopsies in 6 patients. A number of patients had definite features of both classic PAN and microscopic polyarteritis. Conclusions: When compared with other PAN patients, those with FMF tended to have a younger age at PAN onset, more frequent perirenal hematomas, and an overall better prognosis. The cases with overlapping features of microscopic and classic PAN pose a problem for the current classification of vasculitis. We suggest that the clinical representation of PAN in FMF patients has certain characteristics and may be a feature of FMF per se. Copyright © 2001 by W.B. Saunders Company.en_US
dc.identifier.doi10.1053/sarh.2001.19958
dc.identifier.endpage287en_US
dc.identifier.issn0049-0172
dc.identifier.issue4en_US
dc.identifier.pmid11182028
dc.identifier.scopus2-s2.0-0035111463
dc.identifier.scopusqualityQ1
dc.identifier.startpage281en_US
dc.identifier.urihttps://doi.org/10.1053/sarh.2001.19958
dc.identifier.volume30en_US
dc.identifier.wosWOS:000167127700006
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherW B Saunders Coen_US
dc.relation.ispartofSeminars in Arthritis and Rheumatismen_US
dc.relation.journalSeminars in Arthritis and Rheumatismen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFamilial Mediterranean Feveren_US
dc.subjectPolyarteritis Nodosaen_US
dc.titlePolyarteritis Nodosa in Patients With Familial Mediterranean Fever (FMF): A Concomitant Disease or a Feature of FMFen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files